Clinical Trial Update: Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing filgrastim with chemotherapy followed by peripheral stem cell transplant in Hodgkin lymphoma and Non-Hodgkin lymphoma. The study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Filgrastim (Neupogen) (filgrastim)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Lymphoma | Phase 2 | Status: COMPLETED